Literature DB >> 22282893

Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage.

Neeraj Badjatia1, David Seres, Amanda Carpenter, J Michael Schmidt, Kiwon Lee, Stephan A Mayer, Jan Claassen, E Sander Connolly, Mitchell S Elkind.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to understand factors related to increases in serum free fatty acid (FFA) levels and association with delayed cerebral ischemia (DCI) after subarachnoid hemorrhage.
METHODS: We performed serial measurement of systemic oxygen consumption by indirect calorimetry and FFA levels by liquid chromatography/mass spectrometry in the first 14 days after ictus in 50 consecutive patients with subarachnoid hemorrhage. Multivariable generalized estimating equation models identified associations with FFA levels in the first 14 days after SAH and Cox proportional hazards model used to identified associations with time to DCI.
RESULTS: There were 187 measurements in 50 patients with subarachnoid hemorrhage (mean age, 56±14 years old; 66% women) with a median Hunt-Hess score of 3. Adjusting for Hunt-Hess grade and daily caloric intake, n-6 and n-3 FFA levels were both associated with oxygen consumption and the modified Fisher score. Fourteen (28%) patients developed DCI on median postbleed Day 7. The modified Fisher score (P=0.01), mean n-6:n-3 FFA ratio (P=0.02), and mean oxygen consumption level (P=0.04) were higher in patients who developed DCI. In a Cox proportional hazards model, the mean n-6:n-3 FFA ratio (P<0.001), younger age (P=0.05), and modified Fisher scale (P=0.004) were associated with time to DCI.
CONCLUSIONS: Injury severity and oxygen consumption hypermetabolism are associated with higher n-FFA levels and an increased n-6:n-3 FFA ratio is associated with DCI. This may indicate a role for interventions that modulate both oxygen consumption and FFA levels to reduce the occurrence of DCI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282893      PMCID: PMC4198386          DOI: 10.1161/STROKEAHA.111.636035

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

Review 2.  Mechanisms of acute brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Joshua B Bederson
Journal:  Neurol Res       Date:  2006-06       Impact factor: 2.448

3.  Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Neeraj Badjatia; Amanda Carpenter; Luis Fernandez; J Michael Schmidt; Stephan A Mayer; Jan Claassen; Kiwon Lee; E Sander Connolly; David Seres; Mitchell S V Elkind
Journal:  Stroke       Date:  2011-07-14       Impact factor: 7.914

4.  Effects of tirilazad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage.

Authors:  H Suzuki; K Kanamaru; M Kuroki; H Sun; S Waga; T Miyazawa
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

5.  Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited.

Authors:  J Claassen; G L Bernardini; K Kreiter; J Bates; Y E Du; D Copeland; E S Connolly; S A Mayer
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

6.  Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study.

Authors:  Xinying Wang; Weiqin Li; Ning Li; Jieshou Li
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 May-Jun       Impact factor: 4.016

7.  Inhibitory effects of eicosapentaenoic acid on chronic cerebral vasospasm after subarachnoid hemorrhage: possible involvement of a sphingosylphosphorylcholine-rho-kinase pathway.

Authors:  Satoshi Shirao; Hirosuke Fujisawa; Akira Kudo; Tetsu Kurokawa; Hiroshi Yoneda; Ichiro Kunitsugu; Kuniaki Ogasawara; Masaaki Soma; Sei Kobayashi; Akira Ogawa; Michiyasu Suzuki
Journal:  Cerebrovasc Dis       Date:  2008-05-30       Impact factor: 2.762

8.  Impact of nosocomial infectious complications after subarachnoid hemorrhage.

Authors:  Jennifer A Frontera; Andres Fernandez; J Michael Schmidt; Jan Claassen; Katja E Wartenberg; Neeraj Badjatia; Augusto Parra; E Sander Connolly; Stephan A Mayer
Journal:  Neurosurgery       Date:  2008-01       Impact factor: 4.654

9.  Free fatty acids in human cerebrospinal fluid following subarachnoid hemorrhage and their potential role in vasospasm: a preliminary observation.

Authors:  Julie G Pilitsis; William M Coplin; Michael H O'Regan; Jody M Wellwood; Fernando G Diaz; Marilynn R Fairfax; Daniel B Michael; John W Phillis
Journal:  J Neurosurg       Date:  2002-08       Impact factor: 5.115

10.  Impact of medical complications on outcome after subarachnoid hemorrhage.

Authors:  Katja E Wartenberg; J Michael Schmidt; Jan Claassen; Richard E Temes; Jennifer A Frontera; Noeleen Ostapkovich; Augusto Parra; E Sander Connolly; Stephan A Mayer
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

View more
  12 in total

1.  High Free Fatty Acid Levels Are Associated with Stroke Recurrence and Poor Functional Outcome in Chinese Patients with Ischemic Stroke.

Authors:  Z Niu; H Hu; F Tang
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

2.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

3.  Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Neeraj Badjatia; Aimee Monahan; Amanda Carpenter; Jacqueline Zimmerman; J Michael Schmidt; Jan Claassen; E Sander Connolly; Stephan A Mayer; Wahida Karmally; David Seres
Journal:  Neurology       Date:  2015-01-16       Impact factor: 9.910

4.  The primary vascular dysregulation syndrome: implications for eye diseases.

Authors:  Josef Flammer; Katarzyna Konieczka; Andreas J Flammer
Journal:  EPMA J       Date:  2013-06-07       Impact factor: 6.543

5.  Fish oil diet associated with acute reperfusion related hemorrhage, and with reduced stroke-related sickness behaviors and motor impairment.

Authors:  Michaela C Pascoe; David W Howells; David P Crewther; Nicki Constantinou; Leeanne M Carey; Sarah S Rewell; Giovanni M Turchini; Gunveen Kaur; Sheila G Crewther
Journal:  Front Neurol       Date:  2014-02-06       Impact factor: 4.003

Review 6.  ROS and brain diseases: the good, the bad, and the ugly.

Authors:  Aurel Popa-Wagner; Smaranda Mitran; Senthilkumar Sivanesan; Edwin Chang; Ana-Maria Buga
Journal:  Oxid Med Cell Longev       Date:  2013-12-05       Impact factor: 6.543

Review 7.  The Role of Omega-3 Polyunsaturated Fatty Acids in Stroke.

Authors:  Jiyuan Bu; Yang Dou; Xiaodi Tian; Zhong Wang; Gang Chen
Journal:  Oxid Med Cell Longev       Date:  2016-06-28       Impact factor: 6.543

8.  Serum glutamine and hospital-acquired infections after aneurysmal subarachnoid hemorrhage.

Authors:  Neeraj Badjatia; Serge Cremers; Jan Claassen; E Sander Connolly; Stephan A Mayer; Wahida Karmally; David Seres
Journal:  Neurology       Date:  2018-06-29       Impact factor: 9.910

9.  Serum lipid profile spectrum and delayed cerebral ischemia following subarachnoid hemorrhage: Is there a relation?

Authors:  Sivashanmugam Dhandapani; Ashish Aggarwal; Anirudh Srinivasan; Rajesh Meena; Sachin Gaudihalli; Harnarayan Singh; Manju Dhandapani; Kanchan K Mukherjee; Sunil K Gupta
Journal:  Surg Neurol Int       Date:  2015-10-23

Review 10.  Dysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review).

Authors:  George B Stefano; Richard M Kream
Journal:  Int J Mol Med       Date:  2016-01-28       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.